Non-specific adsorption surfaces and reactive oxygen species in vaginal milieu

The term "Non-specific adsorption surfaces and reactive oxygen species in vaginal milieu" refers to the complex physiological and biochemical environment of the vaginal cavity that presents significant barriers to effective drug delivery. Non-specific adsorption occurs when proteins present in vaginal secretions, such as mucins and albumin, spontaneously bind to the surfaces of drug delivery vehicles, forming a "protein corona" that can mask targeting ligands and hinder mucus penetration (Monopoli et al., 2012, Nature Nanotechnology). Simultaneously, the vaginal milieu contains reactive oxygen species (ROS), most notably hydrogen peroxide (H2O2), which is primarily produced by commensal Lactobacillus species to maintain a healthy, low-pH environment and defend against pathogens (Valenti et al., 2018, Frontiers in Immunology). While these ROS are essential for host defense, excessive levels can lead to oxidative stress, which is associated with inflammation and the degradation of sensitive pharmaceutical agents. Consequently, this is not a single therapeutic target but a set of environmental parameters that dictate the stability, mucoadhesion, and release profiles of intravaginal formulations. Understanding these factors is critical for the design of advanced drug delivery systems, such as PEGylated nanoparticles or antioxidant-loaded hydrogels, intended to navigate or modulate the vaginal microenvironment. Effective management of these environmental challenges is necessary to ensure the efficacy and safety of treatments for infections, inflammatory conditions, and reproductive health issues.

Other names

Vaginal microenvironmentVaginal oxidative stressVaginal protein coronaVaginal mucosal barrierVaginal redox environment

Not applicable as this is an environmental condition; however, therapeutic strategies involve neutralizing reactive oxygen species or utilizing surface modifications to minimize non-specific protein binding and enhance drug penetration.